Skip to content

Surgical treatment of Dupuytren's disease: A comparison between two surgical approaches

Surgical treatment of Dupuytren's disease: A Randomized clinical trial comparing techniques of partial fasciectomy by Bruner-type surgical access versus zetaplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3hwn66w
Enrollment
Unknown
Registered
2022-06-08
Start date
2017-09-21
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palmar fascial fibromatosis (Dupuytren)

Interventions

Group 1: 31 patients recruited and surgically treated by partial fascial resection using Bruner-type surgical access. Group 2: 31 patients recruited and surgically treated by partial fascial resectio

Sponsors

Universidade Federal de São Paulo
Lead Sponsor
Universidade Federal de São Paulo
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult patients from both sexes; with the diagnostic of Dupuytren; with indication for surgical treatment, defined as the inability to open de palm of the hand on a flat surface

Exclusion criteria

Exclusion criteria: Patients with previous surgery in the hand; diseases that affect hand function; contraindications to surgical procedure

Design outcomes

Primary

MeasureTime frame
Improvement or worsening of the punctuation of the portuguese version of the DASH (Disabilities of the Arm, Shoulder and Hand) Questionaire Score, to be applied at 3 months, 6 months, 1 year and 2 years of post operative follow-up. Study still in progress.

Secondary

MeasureTime frame
Improvement or worsening of the measured range of motion of the affected finger joints in degrees at 1 week, 2 weeks, 1 mont, 3 months, 6 months, 1 year and 2 years of follow-up;Evaluation of pain through the pain visual analogue scale at 1 week, 2 weeks, 1 mont, 3 months, 6 months, 1 year and 2 years of follow-up

Countries

Brazil

Contacts

Public ContactRenan Leão

Universidade Federal de São Paulo

renangleao@gmail.com+55 11 98763-2329

Outcome results

None listed

Source: REBEC (via WHO ICTRP)